Article Per Year (5 Year)
p-Index From 2021 - 2026
1.925
P-Index
This Author published in this journals
All Journal International Journal of Integrative Sciences International Journal of Scientific Multidisciplinary Research (IJSMR) International Journal of Natural and Health Sciences
Anjum Zehra
Unknown Affiliation
Civil Engineering, Building, Construction & Architecture Computer Science & IT Decision Sciences, Operations Research & Management Earth & Planetary Sciences Education Environmental Science Health Professions Industrial & Manufacturing Engineering Law, Crime, Criminology & Criminal Justice Mechanical Engineering Medicine & Pharmacology Social Sciences

Published : 14 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 14 Documents
Search

 1   2 
Corruption in the Pharmaceutical Sector Diagnosing the Challenges Rehan Haider; Asghar Mehdi; Anjum Zehra; Geetha Kumari Das; Zameer Ahmed
International Journal of Integrative Sciences Vol. 3 No. 3 (2024): March 2024
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/ijis.v3i3.7728

Abstract

Corruption inside the pharmaceutical industry is a pervasive and complicated problem that poses giant challenges to healthcare structures, public welfare, and ethical requirements. This abstract delves into the prognosis of the challenges posed by corruption in the pharmaceutical industry. The pharmaceutical sector performs a vital function in promoting international fitness by growing, generating, and distributing life-saving medicines. However, the arena is plagued by various kinds of corruption, such as bribery, fraud, kickbacks, and undue influence on regulatory procedures. This corruption leads to distorted priorities, compromised drug satisfaction, decreased access to important drug treatments, and expanded healthcare costs. One challenge is the complex web of relationships among pharmaceutical corporations, healthcare professionals, and regulatory governments. These relationships, while regularly critical for understanding trade and innovation, may be exploited for corrupt practices that prioritize income over patient well-being. Furthermore, inadequate regulation and susceptible enforcement mechanisms create an environment where corrupt activities can flourish
In Vitro Antioxidative Activity of some Medicinal Plants Rehan Haider; Asghar Mehdi; Anjum Zehra; Geetha Kumari Das; Zameer Ahmed; Sambreen Zameer
International Journal of Integrative Sciences Vol. 3 No. 4 (2024): April 2024
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/ijis.v3i4.7999

Abstract

The artificial antioxidative exercise of curative plants is a topic of meaningful interest on account of the potential healing benefits they concede they offer in fighting oxidative stress-related ailments. This study proposes to judge the antioxidant properties of picked medicinal plants using artificial assays. A range of plants famous for their established curative uses was chosen for inspection, containing [put plant names]. The methods complicated extracting bioactive compounds from the plant fabrics utilizing appropriate solvents and determining their antioxidative potential through miscellaneous assays such as DPPH radical scavenging endeavor, tough lowering antioxidant capacity (FRAP), and total phenolic content decision. These assays provide insights into the strength of the plant extracts to counteract free radicals and defeat oxidative damage. Results marked variable degrees of the antioxidative project between the proven plants, with a few exhibiting effective scavenging facilities against free radicals, while the remainder of something displayed notable phenolic content. These judgments underscore the variety of antioxidative means present in curative plants and desire their potential serviceability as natural beginnings of antioxidants for healing purposes
Nutraceuticals in Diabetes Management Rehan Haider; Asghar Mehdi; Anjum Zehra; Geetha Kumari Das; Zameer Ahmed
International Journal of Integrative Sciences Vol. 3 No. 4 (2024): April 2024
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/ijis.v3i4.8158

Abstract

Nutraceuticals, a suitcase of "food" and "pharmaceuticals," represent a blooming field in the administration of diabetes. With the all-encompassing predominance of diabetes reaching its disquieting dimensions, there is a growing need for complete approaches to complement normal analyses. Nutraceuticals, including bioactive compounds derived from snack beginnings, have attracted attention for their potential to prevent and treat diabetes.Polyphenols in various products, legumes, and teas have shown antagonistic diabetic properties by modulating sweet substance absorption and insulin sensitivity. curcumin fatty Curcumin, a bioactive compound in turmeric, demonstrates antagonistic-instigative and antioxidant properties, providing improved glycemic control. Omega-3 fatty acids, which are widespread in extricate oils, exhibit insulin-sensitizing properties and can diminish diabetic complexities. Additionally, dietary texture—a plethora of whole grains and legumes—aids the level of glucose in blood management and pressure administration. Nutraceuticals offer further glycemic control; however, they still address the associated problems of diabetes. Antioxidant-rich vitamins, such as C and E, protect against oxidative stress, which is involved in diabetic complications. insulin. Furthermore, certain minerals, to a certain degree chromium and magnesium, play crucial roles in insulin, indicating oxygen absorption
Modern Medicine and Pharmaceutics Rehan Haider; Asghar Mehdi; Anjum Zehra; Geetha Kumari Das; Zameer Ahmed; Sambreen Zameer
International Journal of Integrative Sciences Vol. 3 No. 4 (2024): April 2024
Publisher : PT FORMOSA CENDEKIA GLOBAL

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55927/ijis.v3i4.8225

Abstract

Modern Medicine and pharmaceuticals have made tremendous strides in enhancing the healthcare and quality of life of people worldwide. This summary explores the key traits and trends in these fields. In recent decades, current medications have witnessed a paradigm shift toward personalized healthcare. Improvements in genomics, proteomics, and record analytics have paved the way for precision medication and tailoring treatments for an individual's genetic makeup. This technique enhances treatment efficacy while minimizing aspect consequences, marking a significant departure from the one-size-fits-all approach. Pharmaceutical research has experienced a revolution with the advent of biotechnology. Biopharmaceuticals, along with monoclonal antibodies and gene treatment plans, have emerged as powerful tools for the fight against formerly untreatable illnesses. Their ability to target specific molecules or genes has opened new frontiers in cancer treatment, uncommon illnesses, and autoimmune diseases. Furthermore, pharmaceutical enterprises have embraced virtual technologies. AI-pushed drug discovery, in silico medical trials, and telemedicine reshape the drug development pipeline and improve the care of affected persons. In particular, telemedicine has gained prominence, presenting available healthcare offerings and far-flung tracking. However, these advancements have moral and regulatory demands. Privateness issues, information protection, and equitable access to present-day remedies remain essential issues. The need for strong moral frameworks and regulatory oversight is paramount
Co-Authors Ahmed, Zameer Asghar Mehdi Das, Geetha Kumari Geetha Kumari Geetha Kumari Das Haider, Rehan Mehdi, Asghar Naqvi, Rehan Rehan Haider Sambreen Zameer Zameer Ahmed Zameer, Sambreen